• Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us
Sleep Diagnosis and Therapy

Sleep Diagnosis and Therapy

Official Publication of the American Sleep and Breathing Academy

Medicare Dollars Toward DME Are Cost Effective for CPAP

June 13, 2014 by admin

 

A study about Medicare investment in DME concludes that substantial cost savings are realized when mobility, supplemental oxygen, and CPAP therapy are covered by Medicare.

 

The Case for Medicare Investment in DME – 2014 Update was done by Brian Leitten of Leitten Consulting. It is a follow-up to a 2011 study that concluded when Medicare pays for DME, it saves substantially more money in health care costs than it pays for the equipment.

 

“This certainly is not news to those of us in the industry,” said John Gallagher, VGM, vice president-government relations. “We know that Mom wants to be at home, not in a home, and that DME makes that possible.”

The study looked at three major categories of DME:

• CPAP therapy: Obstructive sleep apnea occurs in 70 percent of men over 65, and 56 percent of women. OSA contributes to many serious medical conditions, and is usually treated by continuous positive airway pressure therapy. When Medicare pays for CPAP therapy, the cost of treating medical complications caused by OSA drops dramatically.

• Mobility equipment: Falls are the leading cause of unintentional injury and death in the U.S. for adults 65 and older. When Medicare pays for mobility equipment, falls are reduced and significant net spending savings are realized.

• Supplemental oxygen therapy: COPD is the second leading cause of disability and the third leading cause of death in the U.S. When Medicare pays for supplemental oxygen therapy, the cost of treating medical complications of COPD drops dramatically, and significant net spending savings are realized.

“The message is clear: HME does save Medicare money, and helps beneficiaries live where they want to be – at home,” said Gallagher. The study was discussed at a June 11 Town Hall meeting during the VGM Heartland Conference, attended by mobility users, HME providers, legislators and legislative staff.

To view the complete study, go to  http://www.vgmdclink.com/uploads/library/773099cb9200713f04741d93ee34432c.pdf.

Filed Under: Articles, Blog

Primary Sidebar

More to See

Xywav Oral Solution for Idiopathic Hypersomnia

February 16, 2022 By Alan Hickey

New Insomnia Drug Improves Sleep Outcomes for Adults

February 10, 2022 By Alan Hickey

Tags

apnea CPAP Health Home Sleep Home Sleep Testing insomnia narcolepsy obstructive sleep apnea Sleep sleep apnea sleep apnea symptoms sleep apnea syndrome sleep apnea treatment sleep appliances sleep buisness Sleep Business sleep center Sleep Centers sleep community sleep diagnosis sleep diagnostic sleep diagnostics sleep disease sleep disorder sleep disorder center sleep disordered breathing sleep disorders sleep heart health sleep industry sleeping Sleep Lab sleep labs sleep management sleep medicine sleep monitor sleep physicians sleep problems sleep studies sleep study sleep technologist sleep test sleep testing Technology therapy Treatment

Footer

About SleepDT

SleepDT Sleep Diagnosis and Therapy is a clinical Journal for allied Sleep Professionals, Neurologists, Psychiatrists, Pulmonologists, Primary Care Physicians, and other medical specialists. We also advocate on behalf of patient care in the field of Sleep Medicine

Recent

  • Sleep Hygiene: Which Bedroom Colors to Avoid and which Promote Good Sleep??
  • Xywav Oral Solution for Idiopathic Hypersomnia
  • New Insomnia Drug Improves Sleep Outcomes for Adults
  • Mark Cuban Billionaire Entrepreneur and Television Personality Launches Online Pharmacy for Generic Drugs
  • Americans Say They’re Sleep-Deprived After the Super Bowl

NAVIGATION

  • Home
  • About Us
  • Blog
  • Subscribe to the Journal
  • Contact Us

Copyright © 2022 · Sleep Diagnosis and Therapy